- Home
- CSBR vs SRV Comparison
CSBR vs SRV Comparison
Compare CSBR & SRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CSBR | SRV |
|---|---|---|
| Founded | 1985 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 90.0M | 180.3M |
| IPO Year | 1986 | N/A |
Fundamental Metrics
Financial Performance| Metric | CSBR | SRV |
|---|---|---|
| Price | $7.01 | $40.71 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | 23.1K | ★ 33.9K |
| Earning Date | 12-15-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 13.38% |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.17 | N/A |
| Revenue | ★ $58,424,000.00 | N/A |
| Revenue This Year | $4.84 | N/A |
| Revenue Next Year | $11.51 | N/A |
| P/E Ratio | $40.00 | ★ N/A |
| Revenue Growth | ★ 9.06 | N/A |
| 52 Week Low | $5.59 | $30.73 |
| 52 Week High | $11.99 | $44.30 |
Technical Indicators
Market Signals| Indicator | CSBR | SRV |
|---|---|---|
| Relative Strength Index (RSI) | 52.45 | 51.69 |
| Support Level | $6.74 | $38.11 |
| Resistance Level | $7.39 | $40.30 |
| Average True Range (ATR) | 0.57 | 0.67 |
| MACD | 0.06 | 0.20 |
| Stochastic Oscillator | 37.50 | 94.78 |
Price Performance
Historical ComparisonAbout CSBR Champions Oncology Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
About SRV NXG Cushing Midstream Energy Fund of Beneficial Interest
NXG Cushing Midstream Energy Fund is a non-diversified, closed-end management investment company with an investment objective of seeking a high after-tax total return from a combination of capital appreciation and current income. The fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in midstream energy investments.